Expression of Cathepsin D in early-stage breast cancer and its prognostic and predictive value

被引:5
|
作者
Alhudiri, Inas [1 ,2 ]
Nolan, Christopher [1 ]
Ellis, Ian [1 ]
Elzagheid, Adam [2 ]
Green, Andrew [1 ]
Chapman, Caroline [3 ]
机构
[1] Univ Nottingham, Biodiscovery Inst, Fac Med, Nottingham Breast Canc Res Ctr,Breast Pathol Res G, Nottingham, England
[2] Libyan Biotechnol Res Ctr, Genet Engn Dept, Tripoli, Libya
[3] Nottingham Univ Hosp NHS Trust, Eastern Bowel Canc Screening Hub, Nottingham, England
关键词
Breast cancer; Cathepsin D; Immunohistochemistry; Tissue microarray; Prognosis; GROWTH; ACTIVATION; INHIBITOR; ESTROGEN; SURVIVAL; INDEX; RNA;
D O I
10.1007/s10549-024-07293-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Cathepsin D is a proteolytic enzyme that is normally localized in the lysosomes and is involved in the malignant progression of breast cancer. There are conflicting results regarding Cathepsin D significance as prognostic and predictor marker in breast cancer. This study aimed to evaluate the expression and prognostic significance of Cathepsin D in early-stage breast cancer. Methods Expression of Cathepsin D was assessed by immunohistochemical staining of tissue microarrays, in a large well-characterized series of early-stage operable breast cancer (n = 954) from Nottingham Primary Breast Carcinoma Series between the period of 1988 and 1998 who underwent primary surgery. Correlation of Cathepsin D expression with clinicopathological parameters and prognosis was evaluated. Results Cathepsin D expression was positive in 71.2% (679/954) of breast cancer tumours. Positive expression of Cathepsin D was significantly associated with high histological grade (p = 0.007), pleomorphism (p = 0.002), poor Nottingham Prognostic Index (NPI) score (p < 0.002), recurrence (p = 0.005) and distant metastasis (p < 0.0001). Kaplan-Meier analysis showed that Cathepsin D expression was significantly associated with shorter breast cancer-specific survival (p = 0.001), higher risk of recurrence (p = 0.001) and distant metastasis (p < 0.0001). ER-positive tumours expressing Cathepsin D and treated with tamoxifen demonstrated a significantly higher risk of distant metastasis. Conclusion Cathepsin D expression significantly predicts poor prognosis in breast cancer and is associated with variables of poor prognosis and shorter outcome. The strong association of Cathepsin D with aggressive tumour characteristics and poor outcomes warrants further research of its potential as a therapeutic target The results also suggest a possible interaction between Cathepsin D and tamoxifen therapy in ER-positive breast cancer which needs further investigation to elucidate the underlying mechanisms.
引用
收藏
页码:143 / 153
页数:11
相关论文
共 50 条
  • [31] Simple molecular-grade gene index has prognostic value in early-stage breast cancer
    Nature Clinical Practice Oncology, 2008, 5 (9): : 497 - 497
  • [32] Prognostic value of systemic inflammatory response in early-stage triple-negative breast cancer.
    Ovcaricek, Tanja
    Matos, Erika
    Auprih, Masa
    Borstnar, Simona
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [33] Prognostic Value of Pretreatment Plasma C-Reactive Protein in Patients with Early-Stage Breast Cancer
    Andersen, Hogni H.
    Bojesen, Stig E.
    Johansen, Julia S.
    Ejlertsen, Bent
    Berg, Tobias
    Tuxen, Malgorzata
    Madsen, Kasper
    Dano, Hella
    Flyger, Henrik
    Jensen, Maj-Britt
    Nielsen, Dorte L.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2024, 33 (05) : 662 - 670
  • [34] Shedding Light on the Prognostic and Predictive Value of Circulating Tumor DNA for Management of Patients with Early-Stage Colon Cancer
    Yanes, Rami
    Saridogan, Turcin
    Gorantla, Vikram
    Overacre, Abigail
    Hsieh, Ronan W.
    Celebrezze, James
    Magge, Tara
    Singhi, Meghana
    Saeed, Anwaar
    Zureikat, Amer H.
    Dasari, Arvind N.
    Sahin, Ibrahim Halil
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2025, 24
  • [35] Breast magnetic resonance imaging in early-stage breast cancer: Is there really no value?
    Peters, Nicky H. G. M.
    van den Bosch, Maurice A. A. J.
    Peeters, Petra H. M.
    Mali, Willem M. P. Th.
    Rinkes, Inne H. M. Borel
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (20) : 3465 - 3466
  • [36] Identification of lncRNAs associated with early-stage breast cancer and their prognostic implications
    Rao, Arunagiri Kuha Deva Magendhra
    Patel, Krishna
    Jyothiraj, Suneetha Korivi
    Meenakumari, Balaiah
    Sundersingh, Shirley
    Sridevi, Velusami
    Rajkumar, Thangarajan
    Pandey, Akhilesh
    Chatterjee, Aditi
    Gowda, Harsha
    Mani, Samson
    MOLECULAR ONCOLOGY, 2019, 13 (06) : 1342 - 1355
  • [37] Prognostic and Predictive Value of LIV1 Expression in Early Breast Cancer and by Molecular Subtype
    de Nonneville, Alexandre
    Finetti, Pascal
    Boudin, Laurys
    Denicolai, Emilie
    Birnbaum, Daniel
    Mamessier, Emilie
    Bertucci, Francois
    PHARMACEUTICS, 2023, 15 (03)
  • [38] Analytical Validation of the PreciseDx Digital Prognostic Breast Cancer Test in Early-Stage Breast Cancer
    Fernandez, Gerardo
    Zeineh, Jack
    Prastawa, Marcel
    Scott, Richard
    Madduri, Abishek Sainath
    Shtabsky, Alexander
    Jaffer, Shabnam
    Feliz, Aaron
    Veremis, Brandon
    Mejias, Juan Carlos
    Charytonowicz, Elizabeth
    Gladoun, Nataliya
    Koll, Giovanni
    Cruz, Kristian
    Malinowski, Doug
    Donovan, Michael J.
    CLINICAL BREAST CANCER, 2024, 24 (02) : 93 - 102.e6
  • [40] The expression and prognostic value of protein tyrosine kinase 6 in early-stage cervical squamous cell cancer
    Wang, Xiao-Jing
    Xiong, Ying
    Ma, Ze-Biao
    Xia, Jian-Chuan
    Li, Yan-Fang
    CHINESE JOURNAL OF CANCER, 2016, 35 : 54